These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25667208)

  • 1. What are the effects of medication adherence interventions in rheumatic diseases: a systematic review.
    Galo JS; Mehat P; Rai SK; Avina-Zubieta A; De Vera MA
    Ann Rheum Dis; 2016 Apr; 75(4):667-73. PubMed ID: 25667208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
    Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P;
    Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a group-based intervention to change medication beliefs and improve medication adherence in patients with rheumatoid arthritis: a randomized controlled trial.
    Zwikker HE; van den Ende CH; van Lankveld WG; den Broeder AA; van den Hoogen FH; van de Mosselaar B; van Dulmen S; van den Bemt BJ
    Patient Educ Couns; 2014 Mar; 94(3):356-61. PubMed ID: 24388126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
    Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
    JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study.
    Voshaar M; Vriezekolk J; van Dulmen S; van den Bemt B; van de Laar M
    BMC Musculoskelet Disord; 2016 Oct; 17(1):442. PubMed ID: 27769224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic review.
    Pasma A; van't Spijker A; Hazes JM; Busschbach JJ; Luime JJ
    Semin Arthritis Rheum; 2013 Aug; 43(1):18-28. PubMed ID: 23352247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Duality of Economic Issues With Medication Non-adherence in Patients With Inflammatory Arthritis.
    Campbell NKJ; Saadeldin K; De Vera MA
    Curr Rheumatol Rep; 2017 Sep; 19(10):66. PubMed ID: 28921409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative assessment of medication adherence in patients with rheumatic diseases on biologic therapy.
    Raghunath S; Hijjawi R; Hoon E; Shanahan EM; Goldblatt F
    Clin Rheumatol; 2019 Oct; 38(10):2699-2707. PubMed ID: 31172365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development.
    van Mierlo T; Fournier R; Ingham M
    PLoS One; 2015; 10(6):e0129364. PubMed ID: 26107637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findings.
    Wohlfahrt A; Campos A; Iversen MD; Gagne JJ; Massarotti E; Solomon DH; Feldman CH
    PLoS One; 2018; 13(7):e0200886. PubMed ID: 30024938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases.
    Goh H; Kwan YH; Seah Y; Low LL; Fong W; Thumboo J
    Rheumatol Int; 2017 Oct; 37(10):1619-1628. PubMed ID: 28681249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and content of a group-based intervention to improve medication adherence in non-adherent patients with rheumatoid arthritis.
    Zwikker H; van den Bemt B; van den Ende C; van Lankveld W; den Broeder A; van den Hoogen F; van de Mosselaar B; van Dulmen S
    Patient Educ Couns; 2012 Oct; 89(1):143-51. PubMed ID: 22878029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review.
    Lavielle M; Puyraimond-Zemmour D; Romand X; Gossec L; Senbel E; Pouplin S; Beauvais C; Gutermann L; Mezieres M; Dougados M; Molto A
    RMD Open; 2018; 4(2):e000684. PubMed ID: 30116556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus.
    Gossec L; Molto A; Romand X; Puyraimond-Zemmour D; Lavielle M; Beauvais C; Senbel E; Flipo RM; Pouplin S; Richez C; Saraux A; Mézières M; Gutermann L; Gaudin P; Wendling D; Dougados M
    Joint Bone Spine; 2019 Jan; 86(1):13-19. PubMed ID: 30243782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.
    Shepherd J; Cooper K; Harris P; Picot J; Rose M
    Health Technol Assess; 2016 Apr; 20(34):1-222. PubMed ID: 27135404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
    Hu C; Lu L; Wan JP; Wen C
    Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopause and Rheumatic Disease.
    Talsania M; Scofield RH
    Rheum Dis Clin North Am; 2017 May; 43(2):287-302. PubMed ID: 28390570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature.
    Harrold LR; Andrade SE
    Semin Arthritis Rheum; 2009 Apr; 38(5):396-402. PubMed ID: 18336875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.